Shuren: FDA Willing to Kick-Start Device Evaluation Program, But Funding Guarantee Needed
This article was originally published in The Gray Sheet
CDRH Director Jeff Shuren says FDA is willing to foot the bill for a coordinating center to help launch a new "national device evaluation system," but it is contingent on a guarantee that the program would be funded by the upcoming user fee reauthorization.
You may also be interested in...
If Congress approves a 26% higher 2019 funding request for US FDA's device center, a substantial chunk of those dollars would go to building a novel framework for regulating digital-health technologies, and to help FDA and device manufacturers respond better to cybersecurity vulnerabilities, among other program priorities, according to agency officials.
Two Harvard Medical School professors argue US FDA should put pressure on device manufacturers to complete their post-market studies by withdrawing market authority for devices when sponsors do not meet post-approval commitments. Meanwhile, in the same issue of the Journal of the American Medical Association, a Michigan University researcher suggests tracking products with device-specific CPT codes.
US FDA will be able to tap $30m in user fees over a five-year span to support an independent coordinating center for collection of real-world evidence under its nascent NEST program, according to device center Director Jeff Shuren.